In addition, microRNAs targeting the ATG9A mRNA inhibit autophagy and constitute potential therapeutic tools in pancreatic cancer, acute kidney injury, and cardiac hypertrophy37–39. This evidence concerns the gene ATG9A and pancreatic neoplasm.